MagForce USA, Inc. | Application Preview
MagForce USA, Inc. is seeking government grants to fund various aspects of its clinical trials and operations. The requested funding will cover patient procedures such as MRIs and lab work, payments for Urologists and consultants, payroll for employees, medical supplies, equipment purchases, and the operational costs for its three clinics, warehouse, and headquarters.
The company is in the second stage of FDA clinical trial approval, with plans to submit for the third stage in mid-September. Following approval, MagForce aims to commercialize its innovative treatment machines through sales and leases to hospitals, clinics, and urologists across the nation.
MagForce USA focuses on developing NanoTherm therapy, which aims to treat cancer lesions in patients with intermediate risk prostate cancer while minimizing side effects. The organization is committed to enhancing the quality of life for prostate cancer patients globally.
Currently, MagForce has no direct competition as it is a pioneer in this treatment method, distinguishing itself with its proprietary NanoTechnology that offers fewer side effects compared to existing harsh treatments for prostate cancer. This unique approach positions the company to potentially expand its innovative technology for treating various types of cancer in the future.
-
General Information
Business Registration Number: 46-5051198
Location: Las Vegas, NV, United States
Length of Operation: 6
Number of Employees:
Annual Gross Income:
Annual Gross Expense:
Open to Loans: YES
-
Funding Usage
Continue clinical trials to include patient procedures (MRIs, CT scans, lab work, prostatectomy), Urologists pay, consultant pay, employee payroll, medical supplies, medical equipment purchases, clinic operations for 3 sites, warehouse operations for 1 site, and headquarters operations for 1 site.
-
Business Plan
We are currently in our second stage of FDA clinical trial approval and will submit for our 3rd stage in mid-September. Once that stage is complete, we hope to go commercial with our machine sales and/or machine leases to hospitals, clinics, and urologists all over the country. MagForce USA is dedicated to the study and pursuit of innovative cancer treatments in order to improve patient care. Our purpose is to develop a NanoTherm therapy that can focally treat cancer lesions with minimal side effects for patients who have progressed to intermediate risk prostate cancer stage and are under active surveillance. We strive to improve the quality of life for patients around the world who have been impacted by prostate cancer.
-
Self Identified Competition
We do not currently have competitors as we are pioneers in this particular type of treatment. The only other options currently available to those with prostate cancer are harsh treatments with various and difficult side effects. MagForce USA is different because of the NanoTechnology used to treat prostate cancer. There is no other company that possesses the technology we do. Our treatment has little to no side effects and will pave the way for treatment other types of cancer by applying this same technology.
-
Contact Applicant
Subscribe to our Administrator Dashboard to gain full access to this application. Learn More
